Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.

Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

31 - 40 von 9737

	31	Modelling the effects of treatment expectations on reward learning Augustat, Nick. - Marburg, 2025
	32	Octreotide subcutaneous depot for acromegaly: a randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1 Ferone, Diego. - Freiburg : Universität, 2025
	33	Once more with feeling Leipzig : Deutsche Nationalbibliothek, 2025
	34	Oral peptide therapeutics as an emerging treatment modality in immune-mediated inflammatory diseases: a narrative review Stein Gold, Linda F.. - Freiburg : Universität, 2025
	35	Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects Weissgerber, Anaelle. - Freiburg : Universität, 2025
	36	Paranormale Behauptungen auf dem Prüfstand Jachan, Michael. - Berlin, Heidelberg : Springer Berlin Heidelberg, Imprint: Springer, 2025, 1st ed. 2025
	37	Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study Gratzke, Christian. - Freiburg : Universität, 2025
	38	Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial Müller, Michael J.. - Freiburg : Universität, 2025
	39	Pharmacological antiemetic prophylaxis and treatment for opioid-induced nausea and vomiting (OINV) in patients treated for cancer pain and cancer-related breathlessness Gärtner, Jan Rupert. - Freiburg : Universität, 2025
	40	Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS DeZern, Amy E.. - Freiburg : Universität, 2025